Helen Wiseman

7.8k total citations · 1 hit paper
83 papers, 6.2k citations indexed

About

Helen Wiseman is a scholar working on Biochemistry, Pathology and Forensic Medicine and Genetics. According to data from OpenAlex, Helen Wiseman has authored 83 papers receiving a total of 6.2k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Biochemistry, 27 papers in Pathology and Forensic Medicine and 24 papers in Genetics. Recurrent topics in Helen Wiseman's work include Antioxidant Activity and Oxidative Stress (26 papers), Phytoestrogen effects and research (23 papers) and Estrogen and related hormone effects (21 papers). Helen Wiseman is often cited by papers focused on Antioxidant Activity and Oxidative Stress (26 papers), Phytoestrogen effects and research (23 papers) and Estrogen and related hormone effects (21 papers). Helen Wiseman collaborates with scholars based in United Kingdom, United States and Canada. Helen Wiseman's co-authors include Barry Halliwell, T. A. B. Sanders, Elizabeth A. Bowey, Ian Rowland, Victor Darley‐Usmar, Herman Adlercreutz, Sandra E. File, James O’Reilly, H. R. V. Arnstein and Anthony I. Mallet and has published in prestigious journals such as American Journal of Clinical Nutrition, Analytical Biochemistry and Journal of Agricultural and Food Chemistry.

In The Last Decade

Helen Wiseman

83 papers receiving 5.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Damage to DNA by reactive oxygen and nitrogen species: role in inflammatory disease and progression to cancer

1996 1.9k citations Helen Wiseman, Barry Halliwell profile →

Peers

Countries citing papers authored by Helen Wiseman

Since Specialization

Citations

This map shows the geographic impact of Helen Wiseman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helen Wiseman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helen Wiseman more than expected).

Fields of papers citing papers by Helen Wiseman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Helen Wiseman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helen Wiseman. The network helps show where Helen Wiseman may publish in the future.

Co-authorship network of co-authors of Helen Wiseman

This figure shows the co-authorship network connecting the top 25 collaborators of Helen Wiseman. A scholar is included among the top collaborators of Helen Wiseman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Helen Wiseman. Helen Wiseman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Optimisation of shock wave lithotripsy: a systematic review of technical aspects to improve outcomes 2019 ·Translational Andrology and Urology ·Su‐Min Lee, (unknown), Helen Wiseman, Joe Philip	16
2	Health benefits of isoflavones in functional foods? Proteomic and metabonomic advances 2008 ·Inflammopharmacology ·Max Wong, Peter W. Emery, Victor R. Preedy, Helen Wiseman	26
3	The cytoprotective effect of α-tocopherol and daidzein against d-galactosamine–induced oxidative damage in the rat liver 2007 ·Metabolism ·Max Wong, Bernard Portmann, Roy Sherwood, Onni Niemelä, Heidi Koivisto, Seppo Parkkila, Keith D. Trick, Mary R. L’Abbé, J. H. P. Wilson, Philip R. Dash, Raj Srirajaskanthan, Victor R. Preedy, Helen Wiseman	26
4	Molecular and Cellular Events in Alcohol‐Induced Muscle Disease 2007 ·Alcoholism Clinical and Experimental Research ·(unknown), Victor R. Preedy, Charles H. Lang, Emilio González‐Reimers, Maria C. Arno, (unknown), Helen Wiseman, Shaobo Zhou, Peter W. Emery, Tsutomu Nakahara, Kenji Hashimoto, Makito Hirano, Francisco Santolaria-Fernández, Tomás González‐Hernández, Francesc Fatjó, Emilio Sacanella, Ramón Estruch, José M. Nicolás, Á Urbano-Márquez	74
5	Influence of 10 wk of soy consumption on plasma concentrations and excretion of isoflavonoids and on gut microflora metabolism in healthy adults 2004 ·American Journal of Clinical Nutrition ·Helen Wiseman, (unknown), Elizabeth A. Bowey, (unknown), (unknown), Ian Rowland, Antony S. Lloyd, (unknown), Richard Thompson, Don Clarke	110
6	Influence of soya-based infant formula consumption on isoflavone and gut microflora metabolite concentrations in urine and on faecal microflora composition and metabolic activity in infants and children 2004 ·British Journal Of Nutrition ·Leane Hoey, Ian Rowland, Antony S. Lloyd, Don Clarke, Helen Wiseman	59
7	Improved cognitive function in postmenopausal women after 12 weeks of consumption of a soya extract containing isoflavones 2003 ·Pharmacology Biochemistry and Behavior ·(unknown), Helen Wiseman, Sandra E. File	142
8	Moderate intakes of intact soy protein rich in isoflavones compared with ethanol-extracted soy protein increase HDL but do not influence transforming growth factor β1 concentrations and hemostatic risk factors for coronary heart disease in healthy subjects 2002 ·American Journal of Clinical Nutrition ·T. A. B. Sanders, (unknown), David J. Grainger, George J. Miller, Helen Wiseman	53
9	Eating soya improves human memory 2001 ·Psychopharmacology ·Sandra E. File, (unknown), Emma Fluck, (unknown), (unknown), Helen Wiseman	179
10	The therapeutic potential of phytoestrogens 2000 ·Expert Opinion on Investigational Drugs ·Helen Wiseman	83
11	The bioavailability of non-nutrient plant factors: dietary flavonoids and phyto-oestrogens 1999 ·Proceedings of The Nutrition Society ·Helen Wiseman	96
12	DNA damage and cancer: Measurement and mechanism 1995 ·Cancer Letters ·Helen Wiseman, Harparkash Kaur, Barry Halliwell	108
13	[60] Tamoxifen and estrogens as membrane antioxidants: Comparison with cholesterol 1994 ·Methods in enzymology on CD-ROM/Methods in enzymology ·Helen Wiseman	14
14	The Antioxidant Action of Synthetic Oestrogens Involves Decreased Membrane Fluidity: Relevance to Their Potential Use as Anticancer and Cardioprotective Agents Compared to Tamoxifen? 1994 ·Free Radical Research ·Helen Wiseman, Peter J. Quinn	23
15	Enhancement by tamoxifen of the membrane antioxidant action of the yeast membrane sterol ergosterol: relevance to the antiyeast and anticancer action of tamoxifen 1993 ·Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease ·Helen Wiseman, Michael Cannon, H. R. V. Arnstein, Barry Halliwell	34
16	Tamoxifen and related compounds decrease membrane fluidity in liposomes 1993 ·FEBS Letters ·Helen Wiseman, Peter J. Quinn, Barry Halliwell	91
17	Tamoxifen inhibits lipid peroxidation in cardiac microsomes 1993 ·Biochemical Pharmacology ·Helen Wiseman, Michael Cannon, H. R. V. Arnstein, Barry Halliwell	25
18	Droloxifene (3-hydroxytamoxifen) has membrane antioxidant ability: potential relevance to its mechanism of therapeutic action in breast cancer 1992 ·Cancer Letters ·Helen Wiseman, (unknown), Barry Halliwell, Michael Cannon, H. R. V. Arnstein, M. S. Lennard	14
19	Mechanism of inhibition of lipid peroxidation by tamoxifen and 4‐hydroxytamoxifen introduced into liposomes 1990 ·FEBS Letters ·Helen Wiseman, Mark Cannon, H. R. V. Arnstein, Barry Halliwell	39
20	The antioxidant action of tamoxifen and its metabolites Inhibition of lipid peroxidation 1990 ·FEBS Letters ·Helen Wiseman, (unknown), H. R. V. Arnstein, Michael Cannon, Barry Halliwell	63

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact